22 of 49
Overview of Sales, Earnings and Financial PositionOperating EnvironmentChanges in Corporate StructurePerformance by Subgroup and SegmentPerformance by RegionValue ManagementLiquidity and Capital ResourcesEarnings PerformanceAsset and Capital StructureProposal for Distribution of the ProfitEmployeesProcurement and DistributionResearch and DevelopmentSustainable DevelopmentCorporate Social ResponsibilityCompensation ReportRisk ReportSubsequent EventsFuture PerspectivesAwards 2006/2007Bayer Schering Pharma off to a successful startNew formulating technology from Bayer CropScienceBayer and UNEP reinforce partnershipStart-up company for luminescent filmBayer divests interest in GE Bayer SiliconesProducing antibodies in plantsBayer plans to acquire Ure-Tech Group of TaiwanSector’s largest R&D budgetBayer HealthCare steps up OTC presence in ChinaPhase III study for rivaroxaban under wayAdvent and Carlyle acquire H.C. StarckBayer to invest US$ 1.8 billion in Shanghai through 2009Acquisitions strengthen U.S. cottonseed business Dow to acquire Wolff Walsrode from BayerSale of diagnostics business completed“Combating Climate Change” initiative signedManagement's Statement of ResponsibilityAuditor’s ReportStatements of IncomeBalance SheetsStatements of Cash FlowsStatements of Recognized Income and Expense
NotesKey Data by Segment and RegionGeneral InformationEffects of new accounting pronouncementsBasic principles of the consolidated financial statementsCritical accounting policiesSegment reportingChanges in the Bayer GroupNotes to the Statements of IncomeNotes to the Balance SheetsNotes to the Statements of Cash FlowsOther information
Bayer LinksBayer GlobalBayer HealthCareBayer CropScienceBayer MaterialScienceBayer Business ServicesBayer Technology ServicesCurrenta
back to overview
Search
Services
Calendar
Info
Bookmark this page
E-mail this page
Advanced Search